Yidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial

Bulletin Express

04/28

Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.

The contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.

According to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.

The Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1192500227"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1192500227\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1192500227?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192500227","market":"us","top_or_hot":-1,"title":"Yidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial","media":"Bulletin Express","content":"<p>Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.</p>\n<p>The contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.</p>\n<p>According to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.</p>\n<p>The Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-04-28 21:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.</p>\n<p>The contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.</p>\n<p>According to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.</p>\n<p>The Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02158","symbol_name":"醫渡科技","start_time":0,"source_url":"","article_id":"1192500227","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192500227","pubTimestamp":1777382665,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02158":"医渡科技"},"translate_title":"医渡科技获得人民币409万元合同，为PIONEER2临床试验提供SMO技术服务","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02158":1},"content_text":"Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.\nThe contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.\nAccording to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.\nThe Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}